1. HBW Insight
  2. >>Wellness

GSK In 'Countdown Mode' To Consumer Split As Full Year Sales Slip Back

 
• By Tom Gallen

Two months on from GSK’s rejection of a £50bn bid for Consumer Healthcare from Unilever – and with other suitors seemingly yet to materialize – CEO Emma Walmsley is pressing ahead with the plan to spin off the business in mid-2022. GSK will be buoyed by a strong showing by Consumer Healthcare in Q4, even through full year sales were down slightly.

LONDON- JUNE, 2018: The GlaxoSmithKline headquarters building in Brentford, west London. A British global pharmaceuticals company.
• Source: Shutterstock

GlaxoSmithKline is now in “full countdown mode” to the demerger of its Consumer Healthcare business, according to CEO Emma Walmsley.

Two months on from GSK’s rejection of a £50bn ($68bn) bid for the business from Unilever – and with other...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

More from Business